NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023
2023 · Journal of the National Comprehensive Cancer Network · 449 citations
https://doi.org/10.6004/jnccn.2023.0020
E
Erminia Massarelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
266
Papers
11.5K
Citations
43
h-index
102
i10-index
Erminia Massarelli is an academic researcher from City Of Hope National Medical Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 43, co-authored 227 publications.
ORCID: 0000-0001-7798-7286Papers by this author
worksImmune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases
2021 · The Oncologist · 167 citations
https://doi.org/10.1002/onco.13931
Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-<b> <i>neu</i> </b> Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer
2004 · Clinical Cancer Research · 136 citations
https://doi.org/10.1158/1078-0432.ccr-0373-3
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease
2003 · Lung Cancer · 124 citations
https://doi.org/10.1016/j.lungcan.2003.09.026
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
2022 · JTO Clinical and Research Reports · 111 citations
https://doi.org/10.1016/j.jtocrr.2022.100332
Integration of artificial intelligence in lung cancer: Rise of the machine
2023 · Cell Reports Medicine · 66 citations
https://doi.org/10.1016/j.xcrm.2023.100933
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat